Exscientia is a pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster.

Their mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success.